The estimated Net Worth of Andrew K Chan is at least $4.39 Milion dollars as of 22 December 2017. Mr. Chan owns over 8,333 units of Cellular Biomedicine Inc stock worth over $3,043,278 and over the last 11 years he sold CBMG stock worth over $496,491. In addition, he makes $847,684 as Senior Vice President - Corporate Business Development, General Counsel, Chief Legal Officer oraz Secretary at Cellular Biomedicine Inc.
Andrew has made over 9 trades of the Cellular Biomedicine Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 8,333 units of CBMG stock worth $99,996 on 22 December 2017.
The largest trade he's ever made was exercising 36,145 units of Cellular Biomedicine Inc stock on 21 September 2015 worth over $112,411. On average, Andrew trades about 5,356 units every 59 days since 2014. As of 22 December 2017 he still owns at least 154,090 units of Cellular Biomedicine Inc stock.
You can see the complete history of Mr. Chan stock trades at the bottom of the page.
Andrew K. Chan J.D. serves as Senior Vice President - Corporate Business Development, General Counsel, Chief Legal Officer, Secretary of the Company. Mr. Chan was with Jazz Semiconductor and held various management roles focusing on business operations, business and corporate development. Prior to 2003, Mr. Chan was Vice President of Business Operations and Supply Chain Management for Mindspeed Technologies. In 2000, Mr. Chan served as Vice President of Supply Chain Management at Conexant Systems. Mindspeed and Jazz were spin-offs of Conexant. Conexant began as a division of Rockwell International, before being spun off as a public company. Previously, Mr. Chan’s focus was in aviation and aerospace services. He served in diverse technical and operations management roles at Eastern Airlines, Continental Express and at Allied Signal (now called Honeywell) as Sr. Director of Strategic Business Development. Mr. Chan earned a B.S. degree in Management from Embry Riddle Aeronautical University and an MBA with specialization in Computer System Management and Operations Research from Nova University. He also holds a Jurisprudence Doctorate (J.D.) degree from South Texas College of Law.
As the Senior Vice President - Corporate Business Development, General Counsel, Chief Legal Officer oraz Secretary of Cellular Biomedicine Inc, the total compensation of Andrew Chan at Cellular Biomedicine Inc is $847,684. There are no executives at Cellular Biomedicine Inc getting paid more.
Andrew Chan is 62, he's been the Senior Vice President - Corporate Business Development, General Counsel, Chief Legal Officer oraz Secretary of Cellular Biomedicine Inc since 2019. There are 3 older and 6 younger executives at Cellular Biomedicine Inc. The oldest executive at Cellular Biomedicine Group Inc is Edward Schafer, 74, who is the Non-Executive Independent Director.
Andrew's mailing address filed with the SEC is C/O CELLULAR BIOMEDICINE GROUP, INC., 9605 MEDICAL CENTER DR, SUITE 100, ROCKVILLE, MD, 20850.
Over the last 13 years, insiders at Cellular Biomedicine Inc have traded over $5,441,696 worth of Cellular Biomedicine Inc stock and bought 262,367 units worth $1,621,804 . The most active insiders traders include Keith Wong, Wei (William) Cao oraz Pak To Venture Garden Ltd F.... On average, Cellular Biomedicine Inc executives and independent directors trade stock every 84 days with the average trade being worth of $911,976. The most recent stock trade was executed by Wen Tao Liu on 10 April 2018, trading 22,444 units of CBMG stock currently worth $348,555.
Cellular Biomedicine Inc executives and other stock owners filed with the SEC include: